Informazioni sul prodotto
Linerixibat is a drug that has been shown to reduce the accumulation of fat in the liver by inhibiting the synthesis and secretion of bile acids. Linerixibat also inhibits glucose transport, leading to a reduction in plasma glucose levels. It is also used as a pharmacological agent for the treatment of cholestatic liver diseases. In vitro assays have been performed on human hepatocytes to investigate Linerixibat's biological properties and its effects on multidrug resistance-associated protein (MRP2). These assays show that Linerixibat increases MRP2 expression, which leads to increased serum levels of drugs such as cyclosporin A.
Proprietà chimiche
Richiesta tecnica su: 3D-VDC98269 Linerixibat
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
